5 news items
Ocular Therapeutix® to Host Investor Day on June 13, 2024
OCUL
5 Jun 24
Event to feature prominent retinal disease experts Baruch D. Kuppermann, MD, PhD (University of California, Irvine) and Dilsher S. Dhoot, MD (California
The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
OCUL
16 Apr 24
unveils how financial experts perceive Ocular Therapeutix. The following summary outlines key analysts, their recent evaluations, and adjustments
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
OCUL
16 Apr 24
-up/smaller organizations. Dr. Gibson is a recognized expert in clinical trial design and execution, with significant experience in launch/pipeline
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
OCUL
6 Apr 24
team of recognized experts in place to strengthen the Company's retinal expertise, I believe we are on a solid path to enrich and accelerate the AXPAXLI
Decoding 6 Analyst Evaluations For Ocular Therapeutix
OCUL
13 Mar 24
unveils how financial experts perceive Ocular Therapeutix. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings
- Prev
- 1
- Next